Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-18-055216
Filing Date
2018-10-25
Accepted
2018-10-24 21:11:00
Documents
4
Period of Report
2018-10-24

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tv505398_6k.htm 6-K 12968
2 EXHIBIT 99.1 tv505398_ex99-1.htm EX-99.1 254434
3 EXHIBIT 99.2 tv505398_ex99-2.htm EX-99.2 10345
4 GRAPHIC image_001.jpg GRAPHIC 4443
  Complete submission text file 0001144204-18-055216.txt   285011
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 181137435
SIC: 2834 Pharmaceutical Preparations